Voltaren Forte 2.32% Gel Diclofenac diethylamine

Voltaren is a widely recognized brand for the relief of joint and muscle pain, primarily known for its active ingredient, diclofenac. The brand was originally developed in Switzerland by Ciba-Geigy, which later became part of the pharmaceutical giant Novartis in 1996.

Over the years, the brand transitioned from a prescription-only medication to a global over-the-counter (OTC) powerhouse. In 2015, a joint venture between Novartis and GlaxoSmithKline created GSK Consumer Healthcare, which eventually took full ownership of the brand. In 2022, this consumer division was spun off into an independent company called Haleon.

Today, Haleon operates as the ultimate owner of Voltaren, headquartered in the United Kingdom. While the brand originated in Switzerland, it is manufactured in several strategic locations worldwide, including Germany, Switzerland, and various regional hubs, to serve international markets.